Chronic Kidney Disease and Calciphylaxis: A Literature Review

Area of Science:

• Nephrology
• Vascular Medicine
• Dermatology

Background:

• Calcific uremic arteriolopathy (CUA), or calciphylaxis, is a rare but severe complication linked to chronic kidney disease (CKD).
• The incidence of CUA is rising due to improved physician awareness and diagnostic capabilities.
• Calciphylaxis represents a critical metabolic disorder with a high mortality rate if not managed effectively.

Purpose of the Study:

• To emphasize the critical need for enhanced research into calciphylaxis.
• To advocate for the development of standardized diagnostic criteria and treatment protocols for CUA.
• To address the challenges posed by calciphylaxis's varied clinical manifestations and poor prognosis.

Main Methods:

• This study is a review of current literature on calcific uremic arteriolopathy.
• Analysis of existing data regarding the diagnosis and management of calciphylaxis.
• Synthesis of information to highlight research gaps and clinical challenges.

Main Results:

• Calciphylaxis presents a significant clinical challenge due to its diverse presentations.
• The condition is associated with a high mortality rate, often within one year of diagnosis.
• There is a growing need for better diagnostic tools and therapeutic strategies.

Conclusions:

• Prompt diagnosis and effective treatment guidelines for calciphylaxis are urgently required.
• Further research is essential to improve the management and outcomes for patients with CUA.
• Addressing the complexities of calciphylaxis is crucial for reducing its fatal impact in CKD patients.